2023
Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history
Wang C, Tian X, Feng X, Demuyakor A, Hu S, Wang Y, Li L, Cui L, Dong F, Dai J, Lei F, Xu Y, Du Z, Shi M, Liu J, Xing L, E M. Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history. Atherosclerosis 2023, 378: 117118. PMID: 37127496, DOI: 10.1016/j.atherosclerosis.2023.03.023.Peer-Reviewed Original ResearchConceptsAcute coronary syndrome patientsAcute coronary syndromeMaximum lipid arcOptical coherence tomographyThin-cap fibroatheromaCancer historyFibrous cap thicknessPercutaneous coronary interventionNonculprit lesionsLipid arcPrevalence of high-risk plaqueIncidence of thin-cap fibroatheromaCulprit lesionPrevalence of acute coronary syndromeHigh-risk plaque featuresHigher incidencePlaque characteristicsTime of percutaneous coronary interventionAssociated with high mortalityCharacteristics of coronary plaquesLipid indicesAbsence of cancer historyCoronary syndrome patientsNon-culprit lesionsIncidence of calcification
2017
SYSTEMIC PENTRAXIN 3 IS A POTENTIAL BIOMARKER TO DIFFERENTIATE PLAQUE EROSION FROM PLAQUE RUPTURE IN ACUTE CORONARY SYNDROME PATIENTS
Mustafina I, Hu S, Jia H, Zheng G, Liu W, Li L, Zhu Y, Wang C, Afolabi A, Zhe C, Wang Y, Dong H, Zhang X, Lin L, Fu Y, Zhang S, Liu Y, Zhang S, Zagidullin N, Jang I, Yu B. SYSTEMIC PENTRAXIN 3 IS A POTENTIAL BIOMARKER TO DIFFERENTIATE PLAQUE EROSION FROM PLAQUE RUPTURE IN ACUTE CORONARY SYNDROME PATIENTS. Journal Of The American College Of Cardiology 2017, 69: 1280. DOI: 10.1016/s0735-1097(17)34669-7.Peer-Reviewed Original Research